GLENMARK
Invest Now
Glenmark Pharmaceuticals Share Price
₹1,492.65 +6.9 (0.46%)
19 Nov, 2024 16:50
Start SIP in GLENMARK
Start SIPPerformance
- Low
- ₹1,473
- High
- ₹1,518
- 52 Week Low
- ₹761
- 52 Week High
- ₹1,831
- Open Price₹1,492
- Previous Close₹1,486
- Volume732,905
Investment Returns
- Over 1 Month -14.14%
- Over 3 Month -4.67%
- Over 6 Month + 43.19%
- Over 1 Year + 92.36%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -48.1
- PEG Ratio
- 0.1
- Market Cap Cr
- 42,121
- P/B Ratio
- 5.4
- Average True Range
- 64.95
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -19.12
- RSI
- 28.56
- MFI
- 22.67
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,492.65
+
6.9
(0.46%)
- Bullish Moving Average 3
- Bearish Moving Average 13
- 20 Day
- ₹1,641.06
- 50 Day
- ₹1,650.34
- 100 Day
- ₹1,558.35
- 200 Day
- ₹1,364.55
Resistance and Support
1520.3
- R3 1,681.45
- R2 1,639.25
- R1 1,562.50
- S1 1,443.55
- S2 1,401.35
- S3 1,324.60
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-11-10 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,492 As on 19 November, 2024 | 16:36
The Market Cap of Glenmark Pharmaceuticals is ₹42120.8 Cr As on 19 November, 2024 | 16:36
The P/E ratio of Glenmark Pharmaceuticals is -48.1 As on 19 November, 2024 | 16:36
The PB ratio of Glenmark Pharmaceuticals is 5.4 As on 19 November, 2024 | 16:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.